Abeba Habtesion

1.2k total citations
22 papers, 829 citations indexed

About

Abeba Habtesion is a scholar working on Hepatology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Abeba Habtesion has authored 22 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 10 papers in Epidemiology and 7 papers in Clinical Biochemistry. Recurrent topics in Abeba Habtesion's work include Liver Disease and Transplantation (14 papers), Liver Disease Diagnosis and Treatment (9 papers) and Metabolism and Genetic Disorders (7 papers). Abeba Habtesion is often cited by papers focused on Liver Disease and Transplantation (14 papers), Liver Disease Diagnosis and Treatment (9 papers) and Metabolism and Genetic Disorders (7 papers). Abeba Habtesion collaborates with scholars based in United Kingdom, Spain and Italy. Abeba Habtesion's co-authors include Rajiv Jalan, Nathan Davies, Rajeshwar P. Mookerjee, Fausto Andreola, Jane Macnaughtan, Steven W.M. Olde Damink, Andrew Hall, Vikram Sharma, Cornelius Engelmann and Annarein Kerbert and has published in prestigious journals such as Hepatology, Gut and Scientific Reports.

In The Last Decade

Abeba Habtesion

22 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abeba Habtesion United Kingdom 14 455 452 160 153 132 22 829
Masato Tsuchiya Japan 16 170 0.4× 224 0.5× 226 1.4× 119 0.8× 84 0.6× 42 766
H Moriwaki Japan 10 290 0.6× 331 0.7× 187 1.2× 68 0.4× 57 0.4× 22 664
Roger Flores‐Costa Spain 13 159 0.3× 264 0.6× 168 1.1× 101 0.7× 44 0.3× 19 581
Mahmoud Abu‐Amara United Kingdom 15 418 0.9× 296 0.7× 122 0.8× 418 2.7× 47 0.4× 20 894
Chia-Yun Lai Taiwan 13 128 0.3× 187 0.4× 101 0.6× 145 0.9× 38 0.3× 35 544
Auvro R. Mridha Australia 8 300 0.7× 818 1.8× 576 3.6× 191 1.2× 53 0.4× 9 1.2k
Masayoshi Yamauchi Japan 16 158 0.3× 379 0.8× 199 1.2× 66 0.4× 42 0.3× 48 739
Kazuaki Tejima Japan 14 204 0.4× 190 0.4× 369 2.3× 138 0.9× 38 0.3× 26 719
Wilhelmus J. Kwanten Belgium 18 375 0.8× 1.0k 2.2× 186 1.2× 157 1.0× 17 0.1× 33 1.3k
Sara Aleffi Italy 10 324 0.7× 550 1.2× 148 0.9× 159 1.0× 31 0.2× 14 803

Countries citing papers authored by Abeba Habtesion

Since Specialization
Citations

This map shows the geographic impact of Abeba Habtesion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abeba Habtesion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abeba Habtesion more than expected).

Fields of papers citing papers by Abeba Habtesion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abeba Habtesion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abeba Habtesion. The network helps show where Abeba Habtesion may publish in the future.

Co-authorship network of co-authors of Abeba Habtesion

This figure shows the co-authorship network connecting the top 25 collaborators of Abeba Habtesion. A scholar is included among the top collaborators of Abeba Habtesion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abeba Habtesion. Abeba Habtesion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engelmann, Cornelius, Abeba Habtesion, Mohsin Hassan, et al.. (2022). Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF. Journal of Hepatology. 77(5). 1325–1338. 60 indexed citations
2.
Angelova, Plamena R., Annarein Kerbert, Abeba Habtesion, et al.. (2022). Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death. JHEP Reports. 4(8). 100510–100510. 34 indexed citations
3.
Hadjihambi, Anna, Cristina Cudalbu, Katarzyna Pierzchała, et al.. (2022). Abnormal brain oxygen homeostasis in an animal model of liver disease. JHEP Reports. 4(8). 100509–100509. 21 indexed citations
4.
Kondo, Takayuki, Stewart Macdonald, Cornelius Engelmann, et al.. (2021). The role of RIPK1 mediated cell death in acute on chronic liver failure. Cell Death and Disease. 13(1). 5–5. 31 indexed citations
5.
Mohamed, Fatma El Zahraa Ammar, Rajiv Jalan, Shane Minogue, et al.. (2021). Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development. Digestive Diseases and Sciences. 67(5). 1806–1821. 8 indexed citations
6.
Soffientini, Ugo, Nigel Beaton, Sukriti Baweja, et al.. (2021). The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury. Frontiers in Cell and Developmental Biology. 9. 668459–668459. 12 indexed citations
7.
Engelmann, Cornelius, Danielle Adebayo, Marc Oria, et al.. (2020). Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure. Scientific Reports. 10(1). 389–389. 30 indexed citations
8.
Engelmann, Cornelius, Mohammed Sheikh, Shreya Sharma, et al.. (2020). Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure. Journal of Hepatology. 73(1). 102–112. 117 indexed citations
9.
Engelmann, Cornelius, Fausto Andreola, Abeba Habtesion, et al.. (2020). Toll-like receptor 4 inhibition acts synergistically with G-CSF to prevent organ injury and induce liver regeneration in acute-on-chronic liver failure. Journal of Hepatology. 73. S28–S28. 2 indexed citations
10.
Hadjihambi, Anna, Ian F. Harrison, Marta Costas‐Rodríguez, et al.. (2018). Impaired brain glymphatic flow in experimental hepatic encephalopathy. Journal of Hepatology. 70(1). 40–49. 72 indexed citations
11.
Chiara, Francesco De, Karen Louise Thomsen, Abeba Habtesion, et al.. (2018). Ammonia: A novel target for the prevention of NAFLD progression in NASH. Journal of Hepatology. 68. S359–S360. 3 indexed citations
12.
Arias, Natalia, Francesco De Chiara, Abeba Habtesion, et al.. (2017). Neurobehavioral disturbances and hyperammonemia are evident in rodent model of NAFLD prior to cirrhosis stages. Journal of Hepatology. 66(1). S601–S602. 1 indexed citations
13.
García‐Martínez, Rita, Fausto Andreola, Gautam Mehta, et al.. (2014). Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure. Journal of Hepatology. 62(4). 799–806. 71 indexed citations
14.
Mohamed, Fatma El Zahraa Ammar, Rajai Al-Jehani, Fausto Andreola, et al.. (2014). Effect of toll‐like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver International. 35(3). 1063–1076. 57 indexed citations
15.
Jover‐Cobos, Maria, Lorette Noiret, Karla Lee, et al.. (2013). Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats. Journal of Hepatology. 60(3). 545–553. 35 indexed citations
16.
Mehta, Gautam, Vikram Sharma, Abeba Habtesion, et al.. (2012). PMO-123 Gene transfer of dimethylarginine dimethylaminohydrolase-1 reduces portal pressure in a rodent model of cirrhosis. Gut. 61(Suppl 2). A123.1–A123. 1 indexed citations
17.
Shah, Naina, Dipok Kumar Dhar, Abeba Habtesion, et al.. (2012). Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. Journal of Hepatology. 56(5). 1047–1053. 97 indexed citations
18.
Mehta, Gaurav, Vikram Sharma, Abeba Habtesion, et al.. (2012). 117 GENE DELIVERY OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE-1 REDUCES PORTAL PRESSURE IN BILE DUCT-LIGATED RATS. Journal of Hepatology. 56. S52–S52. 1 indexed citations
19.
Vairappan, Balasubramaniyan, Gavin Wright, Vikram Sharma, et al.. (2011). Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 302(1). G145–G152. 37 indexed citations
20.
Davies, Nathan, Gavin Wright, Vanessa Stadlbauer, et al.. (2009). L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats #. Hepatology. 50(1). 155–164. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masato Tsuchiya Breakdown of academic impact, for papers by H Moriwaki Breakdown of academic impact, for papers by Roger Flores‐Costa Breakdown of academic impact, for papers by Mahmoud Abu‐Amara Breakdown of academic impact, for papers by Chia-Yun Lai Breakdown of academic impact, for papers by Auvro R. Mridha Breakdown of academic impact, for papers by Masayoshi Yamauchi Breakdown of academic impact, for papers by Kazuaki Tejima Breakdown of academic impact, for papers by Wilhelmus J. Kwanten Breakdown of academic impact, for papers by Sara Aleffi
Rankless by CCL
2026